| Pharmacological management of postoperative ileus. | |
| | |
MedLine Citation:
|
PMID: 19399212 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The duration of postoperative ileus following abdominal surgery is quite variable, and prolonged postoperative ileus is an iatrogenic phenomenon with important influence on patient morbidity, hospital costs and length of stay in hospital. Adequate treatment for prolonged postoperative ileus is important to improve patient morbidity and clinical efficiency. Both clinical and pharmacological management strategies have improved rapidly over the last decade, and appropriate and timely management using multimodal techniques should be used for optimal care. In this review, we define postoperative ileus, describe the pathogenesis and briefly discuss clinical management before detailing potential pharmacologic management options. |
| | |
Authors:
|
Farhad Zeinali; Jonah J Stulberg; Conor P Delaney |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Canadian journal of surgery. Journal canadien de chirurgie Volume: 52 ISSN: 1488-2310 ISO Abbreviation: Can J Surg Publication Date: 2009 Apr |
Date Detail:
|
Created Date: 2009-04-28 Completed Date: 2009-05-21 Revised Date: 2009-11-18 |
Medline Journal Info:
|
Nlm Unique ID: 0372715 Medline TA: Can J Surg Country: Canada |
Other Details:
|
Languages: eng Pagination: 153-7 Citation Subset: IM |
Affiliation:
|
Department of Surgery, University Hospitals Case Medical Center, Cleveland, Ohio 44106-5047, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adrenergic alpha-Antagonists
/
therapeutic use Adrenergic beta-Antagonists / therapeutic use Anti-Inflammatory Agents, Non-Steroidal / therapeutic use Bisacodyl / therapeutic use Cathartics / therapeutic use Cisapride / therapeutic use Dihydroergotamine / therapeutic use Humans Ileus / drug therapy*, physiopathology Inflammation / drug therapy Naltrexone / analogs & derivatives, therapeutic use Neostigmine / therapeutic use Parasympathomimetics / therapeutic use Piperidines / therapeutic use Postoperative Complications / drug therapy* Propranolol / therapeutic use Quaternary Ammonium Compounds / therapeutic use Receptors, Opioid, mu / antagonists & inhibitors Serotonin Agonists / therapeutic use |
| Chemical | |
Reg. No./Substance:
|
0/Adrenergic alpha-Antagonists; 0/Adrenergic beta-Antagonists; 0/Anti-Inflammatory Agents, Non-Steroidal; 0/Cathartics; 0/Parasympathomimetics; 0/Piperidines; 0/Quaternary Ammonium Compounds; 0/Receptors, Opioid, mu; 0/Serotonin Agonists; 0/alvimopan; 16590-41-3/Naltrexone; 511-12-6/Dihydroergotamine; 525-66-6/Propranolol; 59-99-4/Neostigmine; 603-50-9/Bisacodyl; 81098-60-4/Cisapride; 83387-25-1/methylnaltrexone |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Radiation dose from initial trauma assessment and resuscitation: review of the literature.
Next Document: Molecular pathology of lewy body diseases.